3DPrint.com November 25, 2024
Vanesa Listek

Formnext 2024 is known as the world’s leading trade fair for industrial 3D printing, with towering machines and manufacturing giants filling its halls. Amid this industrial frenzy, Axolotl Biosciences, a life sciences company focusing on bioinks for tissue engineering, has carved out a unique space, showcasing its work and proving that biotechnology can thrive on a stage typically dominated by hardware-heavy players.

Axolotl Co-founder and CEO Stephanie Willerth attended Formnext for the first time, where she spoke with 3DPrint.com about the company and its upcoming initiatives.

At this year’s Formnext, Willerth had pitching sessions, live demonstrations, and networking opportunities, including a livestream with YouTube influencer 3D Printing Nerd. This spotlight highlighted Axolotl’s work and showed the growing interest in bioprinting...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: 3D Printing, Biotechnology, Conferences / Podcast, Pharma / Biotech, Technology, Trends
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
FDA Approves First Biosimilar to Omalizumab
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal

Share This Article